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Intracellular pathogens directly alter host cells in
order to replicate and survive. While infection-
induced changes in host transcription can be readily
assessed, posttranscriptional alterations are more
difficult to catalog. We applied the global protein sta-
bility (GPS) platform, which assesses protein stability
based on relative changes in an adjoining fluorescent
tag, to identify changes in the host proteome
following infection with the obligate intracellular bac-
teria Chlamydia trachomatis. Our results indicate
that C. trachomatis profoundly remodels the host
proteome independently of changes in transcription.
Additionally,C. trachomatis replication depends on a
subset of altered proteins, such as Pin1 and Men1,
that regulate the host transcription factor AP-1 con-
trolling host inflammation, stress, and cell survival.
Furthermore, AP-1-dependent transcription is acti-
vated during infection and required for efficient
Chlamydia growth. In summary, this experimental
approach revealed that C. trachomatis broadly
alters host proteins and can be applied to examine
host-pathogen interactions and develop host-based
therapeutics.
INTRODUCTION
Pathogens manipulate host cells for survival, intracellular
replication, and transmission (Ham et al., 2011; Rohmer et al.,
2011).Many intracellular pathogens translocate virulence factors
into the host cytosol (Bingle et al., 2008; Cornelis, 2010), which is
important for survival and replication (Barry et al., 2011; Cossart
and Roy, 2010). Redundancy in the effector repertoire and
targeted host pathways is a complicating factor in our under-
standing of how bacterial effectors function (Gala´n, 2009;
O’Connor et al., 2011). Although transcriptional profiling has
been an important tool for studying host-pathogen interactions
(Burrack and Higgins, 2007), the host response to infection andCell Hostthe function of effectors cannot be determined by microarray
analysis alone because many bacterial effectors act posttran-
scriptionally to modify or alter the stability of host proteins
directly (Ensminger and Isberg, 2010; Misaghi et al., 2006;
Mukherjee et al., 2006).
The obligate intracellular bacteriumChlamydia trachomatis is a
leading cause of bacterial sexually transmitted disease and pre-
ventable blindness worldwide (Holmes, 2008). The elementary
body (EB) is the infectious form of C. trachomatis that develops
into the replicative form, called the reticulate body (RB), upon
uptake into host cells (Moulder, 1991). Replication occurs within
a specialized vacuole known as the inclusion. A type III secretion
system (TTSS) is used by C. trachomatis to deliver bacterial
effectors into the host cytosol during intracellular infection
(Peters et al., 2007). Proteins delivered into the cytosol by
C. trachomatis include two deubiquitinating enzymes and several
proteases. This suggests that C. trachomatis directly manipu-
lates host protein turnover during infection; however, the targets
and activities of most secreted effectors remain largely unknown
(Chellas-Ge´ry et al., 2007; Misaghi et al., 2006; Zhong, 2011).
Our understanding of the manipulation of host proteins by
C. trachomatiswould benefit from an analysis of host cell protein
turnover; however, the methods available to study global
changes to host proteins following infection are limited. Thus,
we adapted the global protein stability (GPS) platform to screen
the human ORFeome following infection with C. trachomatis
(Emanuele et al., 2011; Yen et al., 2008). Hundreds of host
proteins that are altered in stability during infection were identi-
fied, which led to the elucidation of host pathways that are
manipulated during infection. Thus, GPS screening is a powerful
approach that can be applied to the study of bacterial effectors
and for the identification of host pathwaysmanipulated posttran-
scriptionally during pathogen infection.
RESULTS
The Global Protein Stability Platform Identifies
Hundreds of Host Proteins that Are Altered Following
Infection with C. trachomatis
To search for host proteins whose stability is altered following
infection with C. trachomatis, we adapted the GPS screening
platform. GPS is a system originally designed as a fluorescent& Microbe 15, 113–124, January 15, 2014 ª2014 Elsevier Inc. 113
Figure 1. GPS Profiling Identifies Host Proteins Altered during C. trachomatis Infection
(A) Schematic representation of the GPS screen (adapted from Emanuele et al., 2011).
(B) Histograms show the EGFP/DsRed ratio for cells expressing GFP for varying half-lives and the entire GPS library. The cell lines weremock infected (red line) or
infected with C. trachomatis at an moi of 5 (blue line) or 50 (green line) for 24 hr and analyzed by flow cytometry.
(C) Scatter plot for the PSI for each probe in the screen under the two conditions (mock infected versus infected).
(D) A subset of candidates that were tested by expressing the host gene in HEK293T cells. Cells were mock infected (red line) or infected with C. trachomatis
(blue line) for 24 hr and evaluated using flow cytometry. Shown is a representative plot from three independent experiments.
(E) HEK293T cells were mock infected or infected with C. trachomatis for the indicated amount of time. Cells were analyzed by immunoblot for the expression of
the experimental proteins (Dusp16, SNCG, andNCAP-G) as well as b-tubulin (loading control). Blots are representative of at least three independent experiments.
See also Figure S1 and Tables S1, S2, and S4.
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ubiquitin ligases (Emanuele et al., 2011; Yen et al., 2008). The
GPS library was assembled from an arrayed set (ORFeome114 Cell Host & Microbe 15, 113–124, January 15, 2014 ª2014 Elsevv3.1) of 12,000 human open reading frames (ORFs), each
engineered into a retroviral reporter construct whose general
structure is shown in Figure 1A (Emanuele et al., 2011). Theier Inc.
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and an internal ribosome entry site (IRES), permitting the trans-
lation of two fluorescent proteins from one mRNA transcript.
The first fluorescent protein is the internal control DsRed, and
the second is an enhanced GFP (EGFP) expressed as a fusion
to one of 12,000 host cell proteins. When integrated into the
genome of cells, DsRed and EGFP-X are produced at a constant
ratio (independent of transcriptional regulation) because they are
translated from the same mRNA and lack regulatory 50 and 30
UTRs. However, once translated, the amount of DsRed remains
constant, but the level of EGFP changes based on the stability of
the protein fused to its C terminus. When measured by flow
cytometry, this baseline EGFP:DsRed ratio reflects relative
protein stability: the lower the ratio, the less stable the protein
fused to EGFP.
Prior to running the GPS screen, we confirmed that infection
with C. trachomatis does not alter the inherent stability of
EGFP or DsRed. First, we infected cells containing the GPS
cassette with EGFP of varying half-lives at a multiplicity of infec-
tion (moi) of 5 and 50 for 24 hr and then analyzed the samples
by flow cytometry (Figure 1B). Overlays of the EGFP:DsRed
ratio show no noticeable shifts under either infection condition,
indicating that infection does not alter the fluorescent reporter
proteins alone.
We next executed a full-scale GPS screen to identify host
proteins that are altered in stability during infection with
C. trachomatis. We first sorted the uninfected human embryonic
kidney 293T (HEK293T) cells by high-throughput fluorescence-
activated cell sorting (FACS) into seven bins, based on their indi-
vidual EGFP:DsRed ratio, with increasing EGFP:DsRed ratios
corresponding to bins 1–7 (low to high). The ORFs in each bin
were then amplified from genomic DNA using PCR, fluorescently
labeled, and hybridized to custom-designed microarrays (one
microarray per bin). The intensities for each individual probe
from all seven arrays were measured and graphed across
all seven bins. The presence of a cell bearing a particular ORF
in bins of higher numbers indicates that the protein is stable in
the cells; the presence of a cell bearing a particular ORF in
bins of lower numbers indicates that the protein is unstable
in the cells. Using these distributions, we calculated a protein
stability index (PSI) for each ORF. In a parallel experiment, we
infected the HEK293T cells with C. trachomatis EBs at an moi
of 3 for 24 hr. Using the PSI value for each protein in the library
under uninfected and infected conditions, we calculated a
DPSI resulting from infection (Yen et al., 2008). We used a priority
rank system to identify high-confidence hits using a combination
of DPSI, probe intensity, agreement among probes for a single
ORF, and visual inspection of DPSI graphs (described in the
Supplemental Experimental Procedures available online). We
first compared the agreement of each probe for a given ORF
between uninfected and infected conditions, which showed a
linear relationship and an R2 value > 0.85 (Figure 1C). When
comparing probe distributions across the microarrays, the
majority of ORFs examined were indistinguishable, increasing
our confidence in shifts seen following infection (Figure S1A).
We next ordered every ORF by the DPSI, graphed them from
most stabilized (negative DPSI) to most destabilized (positive
DPSI) (Figure 1C), and identified over 600 proteins (out of 8,000
that passed initial filtering from the microarrays) that are alteredCell Hostin stability (absolute value of DPSI > 0.25) following infection with
C. trachomatis (Table S1 and described in detail in the Supple-
mental Experimental Procedures). This included far more
proteins than we anticipated based on previously reported
transcription data and suggested that C. trachomatis profoundly
remodels the host proteome upon infection (Xia et al., 2003).
In order to both estimate robustness of the GPS screen and
validate the proteins identified, we individually cloned a random
subset of 175 (out of 600) unique ORFs into the GPS vector and
transduced HEK293T cells. Cell lines individually expressing a
single EGFP-ORF fusion were then mock infected or infected
with C. trachomatis for 24 hr and analyzed by flow cytometry
to examine changes in the EGFP:DsRed ratio. In these experi-
ments, 109 cell lines (62%) had altered ratios following infection
with C. trachomatis in at least two out of three replicates
(Figure 1D, Table S1). To ensure that these changes accurately
reflected changes at the protein level, 20 random ORFs were
cloned into a retroviral FLAG-tagged vector and used to create
stable cells expressing tagged versions of proteins. We chose
a short epitope tag instead of EGFP to limit concern about the
tag interfering with function of the protein. We then mock in-
fected or infected these cell lines and probed for tagged proteins
in uninfected and infected lysates. A total of 14 of 20 (70%)
showed quantifiable changes by immunoblot, indicating the
reproducibility of our results (Figure S1B). Since GPS is a
screening platform that expresses each ORF independently of
normal transcriptional regulation, we wanted to confirm that a
subset of protein changes was occurring at endogenous levels
of expression following infection with C. trachomatis. Using im-
munoblots, we examined the endogenous levels of nine proteins
and found that seven were altered following infection (Figures 1E
and S1C). We also confirmed several of these protein changes
following infection of HeLa cells (data not shown).
Interestingly, we found that while the GFP fusions accurately
informed us when a specific protein was altered, they did not al-
ways predict whether a protein was stabilized or destabilized.
For example, we identified the host protein SNCG as stabilized
following infection with C. trachomatis using the GPS reporter,
yet immunoblot analysis showed that this protein is actually
cleaved following infection (Figures 1D and 1E). These data
suggest that cleavage of host proteins in the GPS platform can
remove specific degrons, leading to the stabilization of the
EGFP reporter even though cleavage has occurred.
To help integrate our GPS hit data into the overall biology of
the host cell, we conducted bioinformatics analysis using the
database for annotation, visualization, and integrated discovery
(DAVID) clustering analysis (details in Supplemental Experi-
mental Procedures) (Huang et al., 2009). Many proteins in en-
riched clusters recapitulated previous studies of Chlamydia
infection (Table S2). These included chromatin remodeling
proteins, the Golgi apparatus, cell cycle control proteins, and
host cytoskeleton networks, indicating that our GPS data can
identify pathways important for Chlamydia growth (Table S2)
(Balsara et al., 2006; Chumduri et al., 2013; Heuer et al., 2009;
Hybiske and Stephens, 2007; Rejman Lipinski et al., 2009).
Top clusters that include protein families not previously associ-
ated with Chlamydia infection contained transcription factors
and host-signaling cascades such as c-Jun N-terminal kinase
(JNK) (Table S2). Additionally, a number of altered proteins& Microbe 15, 113–124, January 15, 2014 ª2014 Elsevier Inc. 115
Cell Host & Microbe
Chlamydia Infection Alters the Host Proteomewere enriched in the nuclear membrane or mitochondria, sug-
gesting that Chlamydia infection directly alters the makeup of
these intracellular organelles (Table S2).
We next used the data from the GPS screen and our bioinfor-
matics analysis to execute a small-scale proof-of-principle study
to test the whether the subtler interactions we identified could
reveal broader infection-induced alterations to host pathways.
To do this, we mined the GPS data set for proteins that had
robust shifts in EGFP:DsRed and were members of a larger
family of proteins that were otherwise not identified in the screen.
Two protein families we explored were the dual-specificity phos-
phatases (Dusps) and nuclear pore proteins (Nups) that both had
family members shift (Dusp15/16 andNup50/160) (Table S1), but
did not have broad coverage of the entire protein family. To test
whether Chlamydia infection more broadly alters this protein
family, we cloned a larger panel of Dusps (12 members) and
Nups (8 members) into the GPS vector and created stable re-
porter cell lines for each member. We then infected these cells
with Chlamydia and examined the shift of EGFP:DsRed 24 hr
later by flow cytometry. We found that infection with Chlamydia
broadly influenced the stability of 11 out of 12 Dusps and 6 out of
8 Nups, suggesting that this family of proteins may be broadly
altered during infection (Figure S2). Hence, the GPS platform
can drive additional studies that reveal mechanisms in play
during Chlamydia interaction with the host.
Knockdown of a Subset of Altered Host Proteins Inhibits
the Growth of C. trachomatis
To assess the functional consequences of C. trachomatis-
induced altered protein stability, we employed RNAi-mediated
depletion of host proteins that were stabilized during
C. trachomatis infection. If stabilization of these proteins is
important for the intracellular developmental process, then we
would predict that depletion of these proteins would have a
deleterious effect on bacterial growth or replication. We opti-
mized this screen using siRNAs to PTEN, as it has been previ-
ously shown that PTEN depletion leads to decreased bacterial
growth (Figure S2) (Gurumurthy et al., 2010). Cells were trans-
fected with pools of 4 siRNAs for 72 hr, infected with
C. trachomatis, and subsequently evaluated for bacterial growth
by measuring the production of infectious progeny (inclusion
forming units, IFUs). We conducted a siRNA screen of 200
genes in triplicate, including 147 host genes stabilized during
infection and 50 geneswhose stability was not affected by infec-
tion. Of the 147 genes whose stability was altered byChlamydia,
depletion of 26 of them resulted in a decrease of at least 2-fold in
C. trachomatis growth as assessed by IFU analysis. In contrast,
depletion of only 2 out of 50 of the control proteins affected
C. trachomatis growth, suggesting enrichment among stabilized
proteins of host proteins essential for bacterial growth (Table
S3). To further validate these findings, we conducted an RNAi
screen with 4 individual duplexes per gene, and we identified
13 host genes whose knockdown inhibited C. trachomatis
growth with at least two independent duplexes (Table S3).
These data illustrate that a subset of host proteins that were
identified as stabilized following infection are required for
normal Chlamydia growth and suggest that these are host
proteins or pathways that could be targets for host-based
therapeutics.116 Cell Host & Microbe 15, 113–124, January 15, 2014 ª2014 ElsevAs an alternative knockdown method, we selected three
genes (Pin1, Men1, and MAGEA11) that were stabilized in the
GPS screen and created stable knockdown cell lines using two
independent lentivirus-delivered shRNAs for each gene of inter-
est or for control genes. Pin1 andMen1 are involved in regulating
the magnitude host signaling networks, including AP-1, while
MAGEA11 regulates hypoxia-inducible factor 1a (HIF1a) activity
(Aprelikova et al., 2009; Ikeo et al., 2004; Lee et al., 2009; Monje
et al., 2005). Both cellular functions have been implicated as
important during C. trachomatis infection, and we wanted to
confirm their role. Positive transductants were selected with
puromycin, and knockdown was confirmed using immunoblot
(Figure S2E). We then examined the ability of C. trachomatis to
replicate and produce infectious progeny in each knockdown
cell line using two distinct assays: qPCR to quantify the number
ofChlamydia genomes present and titration of infected lysates to
measure IFU production. This allowed us to simultaneously
query the entire Chlamydia life cycle, including redifferentiation
into EBs. When we examined the levels of C. trachomatis by
qPCR, we foundmodest, but reproducible, 1.5- to 2-fold defects
in replication in each knockdown (Figure 2B). However, these
deficiencies were amplified when we examined the production
of infectious progeny, with some knockdowns causing a
reduction of almost 10-fold in IFU (Figures 2C and 2D). We
also examined the development of inclusions in knockdown cells
by fluorescence microscopy. At 30 hr after infection, there was
no significant difference in themorphology of inclusions between
control and experimental knockdown cells. When we quantified
inclusion size, there was trend toward smaller inclusions, yet not
of statistical significance. This suggests that the pathways inter-
acting with these host proteins may be required for late bacterial
replication and/or the redifferentiation of RBs to EBs (Figure S2).
Together, these data confirm that a subset of proteins that are
stabilized during infection with C. trachomatis are also required
for intracellular growth of the pathogen.
AP-1-Dependent Transcription Is Activated following
Infection with C. trachomatis
The bioinformatics analysis of the GPS screen showed a strong
enrichment in kinase signaling cascades and transcription fac-
tors. When we individually examined the role of the 13 genes
identified in the loss-of-function screen using natural language
processing, we also found several genes, including Pin1 and
Men1, that directly influence the activation and amplitude of
the host transcription factor AP-1 (Chen et al., 2009; Chittenden
et al., 2008; Ikeo et al., 2004; Park et al., 2012) (Figure S3). AP-1 is
a heterodimeric transcription factor usually made up of a Jun and
Fos protein that, together, regulate the expression of a large
range of host genes related to inflammation, stress, and cell sur-
vival (Schonthaler et al., 2011). The AP-1 complex is activated
following infection with a wide range of bacterial pathogens,
but its role in C. trachomatis intracellular growth has not been
described. Both Pin1 and Men1 have been shown to augment
c-Jun signaling in human cells (Ikeo et al., 2004; Lee et al.,
2009; Monje et al., 2005). Pin1, which is a prolyl isomerase,
stabilizes phosphorylation-dependent signaling events through
the isomerization of phosphorylated proteins (Lee et al., 2009;
Monje et al., 2005). Men1 prevents transcription of the AP-1
component JunD but augments the signaling cascades drivenier Inc.
Figure 2. Loss-of-Function Screen Identifies Host Proteins that Are Necessary for C. trachomatis Propagation
(A) Distribution of the mean fold change in C. trachomatis IFU production in experimental siRNA knockdown cell lines relative to negative controls.
(B) A subset of stable shRNA knockdown cell lines was infected withC. trachomatis for 48 hr. Levels ofC. trachomatiswere determined by qPCR of the 16S gene
and compared to nontargeting controls. The graphs show the mean levels of C. trachomatis from two independent hairpins ± SD. Shown is one of four
independent experiments (n = 4).
(C) A subset of stable shRNA knockdowns was infected withC. trachomatis for 48 hr. Levels ofC. trachomatiswere determined by IFU production and compared
to nontargeting control hairpins. The graphs show themean IFU ofC. trachomatis produced ± SD for each individual hairpin. All experimental hairpins are p < 0.05
compared to control knockdown by one-way ANOVA. Shown is one of four independent experiments (n = 4).
(D) Representative immunofluorescence micrographs from IFU analysis (103 magnification) from one of three independent experiments (n = 3). See also
Figure S2 and Table S3.
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Chlamydia Infection Alters the Host Proteomeby c-Jun (Ikeo et al., 2004). Therefore, the stabilization of both
Pin1 and Men1 protein during Chlamydia infection would
enhance c-Jun/c-Fos-dependent AP-1 signaling. We first exam-
inedwhether changes in AP-1-dependent transcription occurred
following infection by C. trachomatis by using a reporter cell
line that expresses EGFP in an AP-1-dependent manner. We
mock treated these reporter cells, treated cells with PMA (phor-
bol-12-myristate-13-acetate, a known activator of AP-1-driven
transcription), or infected them with C. trachomatis. At 36 hr
after infection, we analyzed cells by flow cytometry in order to
determine the levels of EGFP. Relative to untreated controls,
there was distinct upregulation of EGFP in Ct-infected cells,
which was evenmore pronounced than that in PMA-treated cells
(Figure 3A). Quantification revealed an increase greater than
3-fold in the mean fluorescence intensity (MFI) of EGFP in
Chlamydia-infected cells compared to control cells (Figure 3B).
These data show that, following infection with C. trachomatis,
AP-1-directed transcription is activated.
The phosphorylation of the AP-1 components c-Jun and c-Fos
is required for AP-1-dependent transcription, so we next
examined these phosphorylation events in cells infected with
C. trachomatis. We mock infected or infected HeLa cells with
C. trachomatis and examined the levels of total and phosphory-
lated c-Jun and c-Fos by immunoblot every 5 hr throughout
infection (Figure 3C). Cells infected with C. trachomatis showed
minimal phosphorylation of c-Fos or c-Jun for the first 20 hr of
infection. However, 20–25 hr after infection, there was a signifi-
cant increase in the phosphorylation of both c-Fos and c-Jun
that increased in magnitude through the remainder of the time
course (Figure 3C). When we examined the levels of total
c-Jun and c-Fos, we found minimal changes in the basal levels
of both proteins throughout infection with C. trachomatis
(Figure 3D). These experiments validated our findings using the
AP-1 reporter and showed that AP-1 is activated late in host cells
infected with C. trachomatis.
We next confirmed the timing of AP-1 activation by examining
the transcriptional activation of two known AP-1 targets using
quantitative RT-PCR. HeLa cells were mock infected or infected
with C. trachomatis for 20 or 30 hr. Cells were then lysed, and
RNAwas purified for expression analysis. Using premixed primer
pairs, we amplified individual genes by RT-PCR in technical du-
plicates to analyze changes in transcription. Experimental genesFigure 3. C. trachomatis Infection Leads to the Activation of the AP-1
(A) pAP-1 EGFP reporter cells were mock infected, infected withC. trachomatis, o
cytometry. A representative plot overlaying the three conditions is shown from th
(B) Quantification of themean fluorescence intensity for each condition from (A) ± S
Student’s t test. Shown is a representative experiment from three completed ex
(C) Immunoblot analysis of phosphorylated c-Fos (top) and c-Jun (bottom) in mo
40 hr. Loading was normalized to actin. Shown is a representative blot from one
(D) Total c-Jun and c-Fos remain unchanged during infection with Chlamydia. He
points, cells were lysed and analyzed for total levels of c-Fos and c-Jun. All lysa
independent experiments.
(E) Indicated shRNA knockdown cells were infected ormock infectedwithChlamy
were determined by immunoblot. Loading was normalized to host actin. Shown
(F) Immunoblot analysis of HeLa cells infected mock infected or infected with C.
phosphorylated SAPK/JNK (top). Shown is a representative blot from four indep
(G) shJUN knockdowns were infected with C. trachomatis for 48 hr. Levels of C. t
control hairpins. The graphs show themean IFU ofC. trachomatis produced ± SD
two completed experiments. All experimental hairpins have p < 0.05 compared t
Cell Hostwere then normalized to host b-actin expression, and the fold
change in infected cells was determined. In line with our immu-
noblot analysis, we saw no changes in mRNA levels of two
AP-1 target genes, c-Fos or JunB, 20 hr after infection or at
any earlier time points examined (Figure S3 and data not shown).
However, 30 hr after infection, we saw a strong induction of the
expression of both c-Fos and JunB mRNA. These data support
our findings that AP-1-dependent transcription is activated
between 20 and 30 hr following C. trachomatis infection.
Because our loss-of-function screen identified genes that
altered C. trachomatis growth and also influence AP-1 signaling
(Figure S3), we were curious whether Chlamydia restriction in
these knockdown cells might be due in part to alterations in the
activation of AP-1. To test this, we mock infected or infected sta-
ble control knockdown cells or cells containing shRNA against
Men1 or Pin1 with C. trachomatis for 40 hr. Cells were then lysed
and probed for the activation of AP-1 components by immuno-
blot. Both shPin1 and shMen1 knockdown cells showed a
significant decrease in the phosphorylation of c-Fos and c-Jun
(Figure 3E) compared to shGFP controls. These data show a
direct link between the loss-of-function data and the activation
of the AP-1 signaling cascade and suggest one potential mech-
anism preventing efficient Chlamydia growth in these cells.
If AP-1-dependent transcription is required for C. trachomatis
growth, we hypothesized that upstream signaling components,
such as the mitogen-activated protein kinase (MAPK) pathways
p38, ERK, and JNK, would also be activated during infection.
These pathways have previously been shown to mediate
c-Jun phosphorylation, and both p38 and ERK are activated
throughout infection with C. trachomatis (Buchholz and Ste-
phens, 2007; Chen et al., 2010). One previous study showed
that inhibition of ERK and p38 leads to continued c-Jun phos-
phorylation (Chen et al., 2010), but we hypothesized that the
JNK pathway may also play a role in this process. Two previous
studies examined JNK activation early following infection with
C. trachomatis and did not observe activation. However, these
reports may have overlooked subtle activation of this cascade
that occurs later during infection (Buchholz and Stephens,
2007; Chen et al., 2010). Therefore, we examined JNK activation
throughout infection with C. trachomatis. We infected HeLa cells
with C. trachomatis and then lysed the cells at various time
points. These lysates were then used to perform a sandwichComplex
r treated with PMA. Then, 30 hr later, EGFP expression was determined by flow
ree experiments (n = 3).
D (n = 3). Both PMA and infection are p < 0.05 compared tomock by two-tailed
periments.
ck-infected HeLa cells or HeLa cells infected with C. trachomatis every 5 hr for
of three independent experiments.
La cells were infected with Chlamydia or mock infected. At the indicated time
tes were normalized using tubulin. Shown is a representative blot from three
dia for 40 hr. Cells were lysed, and the levels of phosphorylated c-Fos and c-Jun
is a representative blot from one of three independent experiments.
trachomatis for 30 hr to determine the levels of total SAPK/JNK (bottom) and
endent experiments.
rachomatis were determined by IFU production and compared to nontargeting
for each individual hairpin (n = 6). Shown is one representative experiment from
o control knockdown by one-way ANOVA. See also Figure S3.
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Figure 4. Inhibition of AP-1 Signaling Prevents C. trachomatis Growth and the Production of Elementary Bodies
(A) HeLa cells were infected with C. trachomatis and then treated with the indicated concentration of JNK inhibitor (SP600125), Pin1 inhibitor (juglone), or vehicle
alone (DMSO or EtOH). The number of Chlamydia genomes was quantified using qPCR at 48 hr after infection. Shown is a representative experiment of four
completed experiments (n = 4). All experimental inhibitor treatments, except 100 nM, are p < 0.05 compared to vehicle control by one-way ANOVA.
(B) Infected HeLa cells were treated with vehicle alone or the indicated inhibitors and fixed 30 hr after infection. Cells were stained for C. trachomatis major
outer membrane protein (MOMP). Top: representative images of C. trachomatis inclusions treated with DMSO, EtOH, SP600125, or juglone (10 mM each at
203 magnification) from one of two independent experiments. Bottom: quantification of average inclusion diameter following inhibitor treatment. p < 0.001 by
Student’s t test (n = 20).
(C) Production of IFU from cells infected with C. trachomatis then treated with the indicated inhibitors for 48 hr (n = 4). All experimental inhibitor treatments are
p < 0.05 compared to vehicle control by one-way ANOVA. Shown is a representative experiment of four independent experiments.
(legend continued on next page)
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lated levels of SAPK/JNK. We found that following infection with
Chlamydia there was a negligible change in the levels of total
SAPK/JNK (Figure S3). However, there was a general accumula-
tion in the levels of phosphorylated SAPK/JNK that increased as
infection progressed, similar to what was observed with c-Fos
and c-Jun (Figure S3). We confirmed these findings by immuno-
blot and determined that infection with C. trachomatis leads to
the phosphorylation of SAPK/JNK, compared to mock-treated
cells (Figure 3F). Taken together, these data show that infection
withC. trachomatis induces AP-1-dependent transcription late in
the developmental cycle and may be influenced by the JNK
signaling cascade.
Since AP-1 complex regulators and robust AP-1 activation
were found to be required for normal Chlamydia growth (Fig-
ure 2), we next directly tested the necessity of AP-1 components
for Chlamydia replication. We created shRNA knockdowns of
c-Jun using two independent hairpins (Figure S3) and compared
the production of infective C. trachomatis progeny in these cells
compared to control shRNA knockdowns (Figure 3G). Con-
sistent with the knockdowns of AP-1-regulating components
(Figures 2D and 2E), depletion of c-Jun significantly reduced
the production of IFU. These data confirm that AP-1 is activated
late during infection and required for C. trachomatis to efficiently
complete its developmental cycle.
AP-1 Activation Is Required for C. trachomatis Growth
In Vitro and In Vivo
One goal of the GPS screen was to identify host proteins or
pathways that are possible targets of small molecules in order
to develop host-based therapeutics that inhibit bacterial growth.
As shown above, the AP-1 complex is activated during infection
with C. trachomatis, and through loss-of-functions screens we
identified that AP-1 activation is required for growth. To test
whether pharmacological inhibitors of this pathway inhibit the
growth and replication ofC. trachomatis, we used two distinct in-
hibitors to prevent AP-1-dependent transcription: SP600125
and juglone (Figure S4). SP600125 is a JNK inhibitor that blocks
upstream activation of the AP-1 complex, while juglone is a
specific inhibitor of Pin1 and prevents prolonged amplification
of AP-1-dependent transcription (Lee et al., 2009). We first
tested the specificity of these inhibitors in infected cells by using
phosphoarray analysis. Infected cells treated with 1 mM
SP600125 or juglone did not alter the activation of a wide range
of host pathways during infection. We also examined the
phosphorylation of c-Jun by immunoblot 40 hr after infection(D) HeLa cells were infected with C. trachomatis and then treated with SP600125
with freshmedia.C. trachomatis levels were determined by qPCR (left) and IFU an
had p < 0.05 compared to vehicle control by one-way ANOVA. Shown is a repre
(E) HeLa cells were infected withC. trachomatis, and treated with SP600125at the
C. trachomatiswere determined by qPCR (left) and IFU analysis (right) (n = 4). All ex
vehicle control by one-way ANOVA. Shown is a representative experiment of fou
(F) HeLa cells were infected with C. trachomatis, and then at the indicated time po
and the levels of C. trachomatis were determined by qPCR (left) and IFU produc
In all experiments, the graphs represent the mean level of C. trachomatis ± SD (n
compared to vehicle control by one-way ANOVA. Shown is a representative exp
(G) Mice were infected transcervically with 106 IFU of C. trachomatis. At 24, 48
vehicle alone. At 6 days after infection, the levels of C. trachomatis were determin
distribution for each treatment group p < 0.01 (n = 10). Shown are the data from
Cell Hostfor all conditions. In the presence of either SP600125 or juglone,
there was a significant decrease in the phosphorylation of c-Jun
compared to the vehicle control, indicating that the inhibitors
directly alter AP-1 signaling. While these findings do not elimi-
nate the possibility of potential off-target effects not included
in our analysis, they suggest that the inhibition of c-Jun phos-
phorylation is partially dependent on JNK signaling.
We next infected HeLa cells with C. trachomatis for 1 hr and
then added media containing various concentrations of
SP600125, juglone, or the vehicle in which they were prepared
(DMSO or EtOH alone). We examined bacterial replication using
qPCR 48 hr following infection. The presence of either SP600125
or juglone at concentrations of 1 mM or higher significantly
decreased the levels of C. trachomatis by qPCR at 48 hr after
infection (Figure 4A), yet low concentrations of either inhibitor
(100 nM) did not alterC. trachomatis growth compared to control
treatments. When we examined inclusions using immunofluo-
rescence microscopy, we noted a significant decrease in the
size of inclusions in the presence of inhibitors (Figure 4B). These
data suggest that inhibiting AP-1 activation can directly alter
C. trachomatis growth.
We next examined IFU production following treatment with
these compounds and found that either inhibitor significantly
decreased the production of infectious progeny at all concentra-
tions tested (Figure 4C). This was surprising based on our data
showing no growth defect as measured by qPCR when using
100 nM concentrations of either inhibitor, yet these data were
consistent with those obtained using shRNA knockdowns,
where the defects in replication were also more pronounced
when measured as IFU (Figures 2C and 2D). We further inhibited
infectious progeny production by combining both inhibitors,
even at low concentrations (Figure S4). Since our Chlamydia
infection time course revealed late activation of AP-1, we con-
ducted a washout experiment to remove the inhibitor at certain
time points after infection. Because juglone is a nonreversible
inhibitor, we chose to run these experiments only with the revers-
ible JNK inhibitor. Cells were infected with C. trachomatis in the
presence of 1 mM SP600125 or DMSO. At 10, 15, or 20 hr after
infection, the media was removed, cells were washed, and fresh
media lacking the inhibitor was added. After allowing the infec-
tion to continue to 48 hr, the cells were lysed, and the levels
and infectivity of C. trachomatis were determined by qPCR and
IFU titration (Figure 4D). When we removed the inhibitor as late
as 15 hr after infection, we found no effect on C. trachomatis
growth or infectivity. However, if we removed the inhibitor
20 hr following infection, we saw a profound defect in Chlamydia. At the indicated times after infection, the inhibitor was removed and replaced
alysis (right) 48 hr after infection (n = 4). Only washout at 20 hr following infection
sentative experiment of four independent experiments.
indicated time points. At 48 hr after infection, cells were lysed and the levels of
perimental inhibitor treatments in the IFU experiment are p < 0.05 compared to
r independent experiments.
ints the cells were treated with juglone. At 48 hr after infection, cells were lysed
tion (right).
= 4). All experimental inhibitor treatments in the IFU experiment are p < 0.05
eriment of four independent experiments.
, and 72 hr after infection, mice were treated with the indicated inhibitors or
ed using qPCR. Graphs show bacterial levels in individual mice and the mean
one of two independent experiments. See also Figure S4.
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dent transcription is not required early in C. trachomatis infec-
tion, but it is required by 20 hr after infection.
As a complement to these experiments, we next added inhib-
itors at certain time points after infection. Cells were infectedwith
C. trachomatis, and SP600125, juglone, or vehicle alone were
added 10, 15, or 20 hr after infection. At 48 hr after infection,
the cells were lysed and we determined the levels and infectivity
of C. trachomatis by qPCR and IFU titration (Figures 4E and 4F).
Similar to the washout experiment, addition of either SP600125
or juglone to infected cells at 10 or 15 hr after infection reduced
C. trachomatis levels and IFU production. Interestingly, addition
of either inhibitor 20 hr after infection had a negligible effect on
the growth of C. trachomatis by qPCR yet caused a significant
decrease in the production of IFU, similar to the defect seen
following inhibitor addition at earlier time points. These data
show that AP-1 signaling is required for efficient C. trachomatis
growth in vitro.
It remained possible that the activation of AP-1 components,
not AP-1-mediated transcription, was required for Chlamydia
growth. To examine whether AP-1-mediated transcription was
also required for intracellular survival, we employed a third
inhibitor, Tanshinone IIA, which allows AP-1 phosphorylation
but prevents DNA binding and subsequent transcriptional activ-
ity (Lee et al., 2008). Cells were infected with C. trachomatis for
20 hr and then treated with various concentrations of Tanshinone
IIA to limit the time of inhibitor treatment. Cells were then lysed
at 48 hr after infection, and bacterial levels and the production
of infectious progeny were determined by qPCR and IFU anal-
ysis, respectively. We saw minimal defects in bacterial growth
by qPCR but observed a significant inhibition in the production
of infectious progeny in a dose-dependent manner (Figure S4).
These data show that preventing AP-1-mediated transcription
directly inhibits the ability ofChlamydia to complete the develop-
mental cycle.
We next wanted to determine whether activation of this
pathway was required for C. trachomatis growth in vivo. We
have recently described a murine model of C. trachomatis infec-
tion that allows the use of human Chlamydia strains in mice and
recapitulatesmanyaspects of humandisease in theupper genital
tract (Gondek et al., 2012). Using this model, mice were infected
transcervically with C. trachomatis and, 24, 48, and 72 hr after
infection, treated with vehicle alone, SP600125, or juglone by
both intraperitoneal (i.p.) injection and transcervical application.
At 6 days after infection, mice were sacrificed, the upper genital
tract was isolated, and the burden of C. trachomatis in the tissue
was determined using qPCR. Treatment of mice with either
SP600125 or juglone led to a 10- to 100-fold decrease in the
levels of C. trachomatis in the upper genital mucosa compared
to vehicle alone (Figure 4G). This suggests that C. trachomatis
requires AP-1-dependent signaling in order to survive in the mu-
rine upper genital mucosa. Together, these results show that
C. trachomatis manipulates host signaling cascades that are
required for bacterial growth both in vitro and in vivo.
DISCUSSION
In this report we applied GPS, a system that probes over
12,000 proteins simultaneously to evaluate how infection with122 Cell Host & Microbe 15, 113–124, January 15, 2014 ª2014 Elsevthe intracellular bacterial pathogenC. trachomatis alters host pro-
tein stability. Some of the proteins identified in the GPS screen,
including the Mcl1 protein and proteins involved in histone mod-
ifications and Golgi functions, were known to be altered during
infection with Chlamydia, validating the screen (Chumduri et al.,
2013; Heuer et al., 2009; Rajalingam et al., 2008). These findings
suggest that Chlamydia broadly remodels the host proteome
during infection, most likely through a variety of mechanisms.
This technology has the potential to uncover important host
therapeutic targets. Therefore, we initially targeted the AP-1
transcription complex; both bioinformatics analysis of the GPS
screen and natural language processing analysis of the loss-
of-function screen indicated that the AP-1 complex is activated
late during Chlamydia infection and required for robust intracel-
lular growth. One of the most intriguing findings was that late
blockade of AP-1 activation had much more dramatic effects
on IFU production than early did AP-1 blockade. This suggests
that AP-1 activity may be required for RB replication and/or
redifferentiation into the EB form. Perhaps the intracellular
growth of C. trachomatis triggers host stress responses, and
C. trachomatis senses these host stress pathways to initiate
differentiation and exit from the failing host cell.
The AP-1 complex is a critical transcription factor that regu-
lates the expression of a large range of host genes in response
to diverse stimuli (Schonthaler et al., 2011). The AP-1 complex
is targeted by several bacterial pathogens to alter cellular
survival or prevent inflammation and cytokine production, with
some pathogens preventing activation and some inducing
activation of upstream host signaling cascades (Alto and Orth,
2012). Interestingly, a recent report using C. pneumoniae sug-
gested that AP-1 activation is responsible for inflammation
seen in vivo (Wang et al., 2012). While the effect of AP-1 on
inflammation during infection in vivo remains to be confirmed
for C. trachomatis, these data together suggest that finely tuned
AP-1 signaling is required for robust intracellular growth. While
our data suggest that AP-1 activity influences C. trachomatis
infection in vivo, we do not yet know whether this is due to
restriction in the epithelial cell or alterations in the subsequent
immune response.
Proteomic approaches are a robust tool by which to charac-
terize unknown host-pathogen interactions. These techniques
should be of particular interest to probe the interactions of the
variety of other pathogens that deliver ubiquitin-modifying pro-
teins to the host cell cytoplasm during infection (Collins and
Brown, 2010). In addition, investigators can compare changes
to the proteome that occur during infection between wild-type
bacteria and strains with loss or gain of function for ubiquitin-
modifying enzymes. Therefore, the experimental approaches
described here provide a blueprint for cataloging host proteins
and pathways that are altered in stability by intracellular patho-
gens. These pathways may be conserved among multiple path-
ogens and could drive the development of therapeutics for these
difficult-to-treat infections.EXPERIMENTAL PROCEDURES
Bacterial Strains, Tissue Culture, Reagents, and Procedures
Full description of Experimental Procedures and reagents used are available in
the Supplemental Information. C. trachomatis serovar L2 434/Bu wasier Inc.
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and qPCR procedures were performed as done previously (Gondek et al.,
2012). For IFU, infected cells were lysed, titered, stained, and quantified by
fluorescence microscopy as done previously. For quantitative PCR, we
measured the level of genomic DNA in samples as done previously. Automated
microscopy was conducted using a Cellomics ArrayScan VTI automated
microscope as done previously.
For immunoblot analysis, cells were lysed in buffer containing 8 M urea, un-
less otherwise indicated, and separated via SDS-PAGE. For all westerns, un-
less indicated, the Odyssey two-color fluorescence imaging system (LI-COR)
was used. Changes in protein content were quantified using Odyssey software
(LI-COR) or ImageJ. All statistics were calculated using Prism Software
(GraphPad), and unless indicated, one-way ANOVA with Tukey’s posttest
was used, with p values under 0.05 considered significant.
GPS Screening and Scoring
GPS screens were performed essentially as described (Emanuele et al., 2011).
Cells were infected with C. trachomatis at an moi of 3, while control cells were
mock infected. At 24 hr following infection, cells were detached and prepared
for cell sorting. Cells were sorted into seven bins per condition, with at least
onemillion cells per bin. Following hybridization, microarray data were normal-
ized and filtered based on the signal:noise ratio, and a DPSI value was calcu-
lated. Probe distribution across bins for treated and untreated samples was
graphed using the included macro.
Bioinformatic Analysis
We used DAVID bioinformatics resources to identify enriched annotation
clusters within the GPS data set, as done previously (Huang et al., 2009).
We uploaded our stabilized and destabilized protein lists independently into
DAVID and used the human proteome as the background list. We used cluster
analysis to identify redundant enriched terms for each group through several
categories, including KEGG pathway and gene ontology terms.
siRNA Screen
siRNA smart pools were picked into 96-well plates from the Dharmacon siRNA
genome set at the Harvard Institute of Chemistry and Cell Biology. HeLa cells
were seeded at a density of 2.5 3 103 into 96-well plates and transfected in
triplicate for 72 hr, when cell viability was evaluated. Cells were then infected
with 104 IFU of C. trachomatis for 48 hr, lysed, diluted 1:1,000 in fresh media,
and used to infect fresh HeLa cells. Then, 24 hr later, cells were fixed with
MeOH stained using DAPI and a fluorescein isothiocyanate (FITC) antibody
to C. trachomatis major outer membrane protein (MOMP; Bio-Rad). Cells
were quantified by automatedmicroscopy as done previously. Themean num-
ber of IFU produced by nontargeting controls for each plate was calculated. A
fold change in C. trachomatis growth was calculated against the nontargeting
mean for each plate. A mean fold change was then calculated for all triplicate
samples.
Inhibitor Treatment
For in vitro experiments, juglone was resuspended in EtOH; for in vivo exper-
iments, juglone was resuspended in DMSO. SP600125 and Tanshinone IIA
were dissolved in DMSO for all experiments. Vehicle controls contained the
appropriate solvent for each experiment. Inhibitors were used at the indicated
concentrations for each experiment.
Mice and In Vivo Inhibitor Treatment
C57BL/6 mice were purchased from The Jackson Laboratory and main-
tained and cared for within the Harvard Medical School Center for Animal
Resources and Comparative Medicine. Mice were treated with medroxy-
progesterone subcutaneously 7 days prior to infection in order to normalize
the estrous cycle. Mice were infected transcervically with 106 IFU of
C. trachomatis. For inhibitor treatments, mice were injected i.p. and trans-
cervically with vehicle alone, 10 mg/kg of SP600125 per injection route
(Wang et al., 2004), and 1 mg/kg of juglone per injection route (Kim
et al., 2010) similar to previous studies. All experiments were approved
by Institutional Animal Care and Use Committee. In all experiments, ten
mice per group were used.Cell HostSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chom.2013.12.009.
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